BioNTech says it will know vaccine’s effectiveness against new variant in two weeks

BioNTech is studying the new COVID-19 variant that emerged in South Africa and said it will know in two weeks if the vaccine it developed with Pfizer is effective against it, The Financial Times reported. The German company said it is testing…